Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Leukemia ; 30(11): 2214-2220, 2016 11.
Article in English | MEDLINE | ID: mdl-27311933

ABSTRACT

The Revised International Prognostic Scoring System (IPSS-R) was developed for untreated myelodysplastic syndrome (MDS) patients based on clinical data. We created and validated a new model that incorporates mutational data to improve the predictive capacity of the IPSS-R in treated MDS patients. Clinical and mutational data from treated MDS patients diagnosed between January 2000 and January 2012 were used to develop the new prognostic system. A total of 508 patients were divided into training (n=333) and validation (n=175) cohorts. Independent significant prognostic factors for survival included age, IPSS-R, EZH2, SF3B1 and TP53. Weighted coefficients for each factor were used to build the new linear predictive model, which produced four prognostic groups: low, intermediate-1, intermediate-2 and high with a median overall survival of 37.4, 23.2, 19.9 and 12.2 months, respectively, P<0.001. Significant improvement in the C-index of the new model (0.73) was observed compared with the IPSS-R (0.69). The new model predicted outcome both in a separate validation cohort and in another cohort of patients with paired samples at different time points during their disease course. The addition of mutational data to the IPSS-R makes it dynamic and enhances its predictive ability in treated MDS patients regardless of their initial or subsequent therapies.


Subject(s)
Models, Biological , Myelodysplastic Syndromes/diagnosis , Risk Assessment/methods , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Mutation , Myelodysplastic Syndromes/genetics , Myelodysplastic Syndromes/mortality , Prognosis , Risk Assessment/standards , Survival Rate , Young Adult
2.
Clin Genitourin Cancer ; 12(2): 111-6, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24331575

ABSTRACT

BACKGROUND: Current treatment modalities for central nervous system (CNS) metastases from renal cell cancer (RCC) include surgical resection, stereotactic radiosurgery (SRS), and whole-brain radiotherapy. Existing studies describing treatment outcomes for CNS metastases include multiple tumor types and thus provide little insight into how RCC CNS metastases respond to these modalities. MATERIALS AND METHODS: RCC patients with brain metastases treated with SRS at the Cleveland Clinic between 1996 and 2010 were retrospectively identified. Radiosurgery and systemic therapy characteristics were recorded. Patients were followed up radiographically at 1 to 2 months after radiosurgery and every 3 to 6 months thereafter with magnetic resonance imaging scans. RESULTS: Of the 166 patients identified, local control was obtained in 90% of patients. In 38% of patients there were additional distant CNS metastases at a median of 12.8 months (95% CI, 8.5-21.1) after SRS. The median time to progression (either local or distant) was estimated to be 9.9 months (95% CI, 5.9-12.9). Higher (> 2.5) RCC-specific graded prognostic assessment (GPA) score was the only factor examined that was found to be a significant prognostic factor for improved outcome (P = .02); however, there was some suggestion that a single target lesion (P = .07) and age ≥ 60 years (P = .07) may also be associated with better CNS control. CONCLUSION: Stereotactic radiosurgery for a limited number of CNS metastases from RCC is associated with excellent local control and is an effective if not preferred treatment modality.


Subject(s)
Brain Neoplasms/surgery , Carcinoma, Renal Cell/surgery , Kidney Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Brain Neoplasms/mortality , Brain Neoplasms/secondary , Carcinoma, Renal Cell/mortality , Carcinoma, Renal Cell/secondary , Combined Modality Therapy , Disease-Free Survival , Female , Humans , Kaplan-Meier Estimate , Kidney Neoplasms/mortality , Kidney Neoplasms/pathology , Male , Middle Aged , Proportional Hazards Models , Radiosurgery , Retrospective Studies , Treatment Outcome
3.
J Cell Sci ; 114(Pt 14): 2673-83, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11683394

ABSTRACT

Scar, a member of the WASp protein family, was discovered in Dictyostelium discoideum during a genetic screen for second-site mutations that suppressed a developmental defect. Disruption of the scar gene reduced the levels of cellular F-actin by 50%. To investigate the role of Scar in endocytosis, phagocytosis and endocytic membrane trafficking, processes that depend on actin polymerization, we have analyzed a Dictyostelium cell line that is genetically null for Scar. Rates of fluid phase macropinocytosis and phagocytosis are significantly reduced in the scar- cell-line. In addition, exocytosis of fluid phase is delayed in these cells and movement of fluid phase from lysosomes to post-lysosomes is also delayed. Inhibition of actin polymerization with cytochalasin A resulted in similar phenotypes, suggesting that Scar-mediated polymerization of the actin cytoskeleton was important in the regulation of these processes. Supporting this conclusion, fluorescence microscopy revealed that some endo-lysosomes were ringed with F-actin in control cells but no F-actin was detected associated with endo-lysosomes in Scar null cells. Disruption of the two genes encoding the actin monomer sequestering protein profilin in wild-type cells causes defects in the rate of pinocytosis and fluid phase efflux. Consistent with a predicted physical interaction between Scar and profilin, disrupting the scar gene in the profilin null background results in greater decreases in the rate of fluid phase internalization and fluid phase release compared to either mutant alone. Taken together, these data support a model in which Scar and profilin functionally interact to regulate internalization of fluid and particles and later steps in the endosomal pathway, probably through regulation of actin cytoskeleton polymerization.


Subject(s)
Contractile Proteins , Dictyostelium/metabolism , Endosomes/metabolism , Phagocytosis/physiology , Pinocytosis/physiology , Proteins/metabolism , Protozoan Proteins , Actins/metabolism , Animals , Dictyostelium/genetics , Exocytosis/physiology , Lysosomes/metabolism , Microfilament Proteins/genetics , Mutagenesis/physiology , Profilins , Protein Transport/physiology , Proteins/genetics , Wiskott-Aldrich Syndrome Protein
4.
Cell Motil Cytoskeleton ; 46(4): 285-304, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10962483

ABSTRACT

Rac1 is a small G-protein in the Ras superfamily that has been implicated in the control of cell growth, adhesion, and the actin-based cytoskeleton. To investigate the role of Rac1 during motile processes, we have established Dictyostelium cell lines that conditionally overexpress epitope-tagged Dictyostelium discoideum wild-type Rac1B (DdRac1B) or a mutant DdRac1B protein. Expression of endogenous levels of myc- or GFP-tagged wild-type DdRac1B had minimal effect on cellular morphologies and behaviors. By contrast, expression of a constitutively active mutant (G12-->V or Q61-->L) or a dominant negative mutant (T17-->N) generated amoebae with characteristic cellular defects. The morphological appearance of actin-containing structures, intracellular levels of F-actin, and cellular responses to chemoattractant closely paralleled the amount of active DdRac1B, indicating a role in upregulating actin cytoskeletal activities. Expression of any of the three mutants inhibited cell growth and cytokinesis, and delayed multicellular development, suggesting that DdRac1B plays important regulatory role(s) during these processes. No significant effects were observed on binding or internalization of latex beads in suspension or on intracellular membrane trafficking. Cells expressing DdRac1B-G12V exhibited defects in fluid-phase endocytosis and the longest developmental delays; DdRac1B-Q61L produced the strongest cytokinesis defect; and DdRac1B-T17N generated intermediate phenotypes. These conditionally expressed DdRac1B proteins should facilitate the identification and characterization of the Rac1 signaling pathway in an organism that is amenable to both biochemical and molecular genetic manipulations.


Subject(s)
Actins/metabolism , Cytoskeleton/physiology , Dictyostelium/physiology , Endocytosis , Neuropeptides/metabolism , rac GTP-Binding Proteins/metabolism , Actins/immunology , Animals , Cell Adhesion , Cell Division , Cell Membrane/metabolism , Cell Movement , Cells, Cultured , Chemotaxis , Dictyostelium/cytology , Dictyostelium/genetics , Dictyostelium/growth & development , Humans , Mutagenesis, Site-Directed , Neuropeptides/genetics , Recombinant Fusion Proteins , Sequence Homology , Signal Transduction , rac GTP-Binding Proteins/genetics , rac1 GTP-Binding Protein
5.
Mol Biol Cell ; 10(2): 393-406, 1999 Feb.
Article in English | MEDLINE | ID: mdl-9950684

ABSTRACT

The function of the small-Mr Ras-like GTPase Rap1 remains largely unknown, but this protein has been demonstrated to regulate cortical actin-based morphologic changes in Dictyostelium and the oxidative burst in mammalian neutrophils. To test whether Rap1 regulates phagocytosis, we biochemically analyzed cell lines that conditionally and modestly overexpressed wild-type [Rap1 WT(+)], constitutively active [Rap1 G12T(+)], and dominant negative [Rap1 S17N(+)] forms of D. discoideum Rap1. The rates of phagocytosis of bacteria and latex beads were significantly higher in Rap1 WT(+) and Rap1 G12T(+) cells and were reduced in Rap1 S17N(+) cells. The addition of inhibitors of protein kinase A, protein kinase G, protein tyrosine kinase, or phosphatidylinositide 3-kinase did not affect phagocytosis rates in wild-type cells. In contrast, the addition of U73122 (a phospholipase C inhibitor), calphostin C (a protein kinase C inhibitor), and BAPTA-AM (an intracellular Ca2+ chelator) reduced phagocytosis rates by 90, 50, and 65%, respectively, suggesting both arms of the phospholipase C signaling pathways played a role in this process. Other protein kinase C-specific inhibitors, such as chelerythrine and bisindolylmaleimide I, did not reduce phagocytosis rates in control cells, suggesting calphostin C was affecting phagocytosis by interfering with a protein containing a diacylglycerol-binding domain. The addition of calphostin C did not reduce phagocytosis rates in Rap1 G12T(+) cells, suggesting that the putative diacylglycerol-binding protein acted upstream in a signaling pathway with Rap1. Surprisingly, macropinocytosis was significantly reduced in Rap1 WT(+) and Rap1 G12T(+) cells compared with control cells. Together our results suggest that Rap1 and Ca2+ may act together to coordinate important early events regulating phagocytosis.


Subject(s)
Dictyostelium/physiology , GTP-Binding Proteins/metabolism , Phagocytosis/physiology , Type C Phospholipases/metabolism , Animals , Calcium/metabolism , Dictyostelium/drug effects , Dictyostelium/genetics , Diglycerides/metabolism , Endosomes/metabolism , Enzyme Inhibitors/pharmacology , Estrenes/pharmacology , GTP-Binding Proteins/genetics , Gene Expression , Genes, Protozoan , Lysosomes/metabolism , Mutation , Naphthalenes/pharmacology , Phagocytosis/drug effects , Protein Kinase C/antagonists & inhibitors , Pyrrolidinones/pharmacology , Signal Transduction , Type C Phospholipases/antagonists & inhibitors , rap GTP-Binding Proteins
6.
Mol Biol Cell ; 9(10): 2891-904, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9763450

ABSTRACT

Rho family proteins have been implicated in regulating various cellular processes, including actin cytoskeleton organization, endocytosis, cell cycle, and gene expression. In this study, we analyzed the function of a novel Dictyostelium discoideum Rho family protein (RacC). A cell line was generated that conditionally overexpressed wild-type RacC three- to fourfold relative to endogenous RacC. Light and scanning electron microscopy indicated that the morphology of the RacC-overexpressing cells [RacC WT(+) cells] was significantly altered compared with control cells. In contrast to the cortical F-actin distribution normally observed, RacC WT(+) cells displayed unusual dorsal and peripheral F-actin-rich surface blebs (petalopodia, for flower-like). Furthermore, phagocytosis in the RacC WT(+) cells was induced threefold relative to control Ax2 cells, whereas fluid-phase pinocytosis was reduced threefold, primarily as the result of an inhibition of macropinocytosis. Efflux of fluid-phase markers was also reduced in the RacC WT(+) cells, suggesting that RacC may regulate postinternalization steps along the endolysosomal pathway. Treatment of cells with Wortmannin and LY294002 (phosphatidylinositol 3-kinase inhibitors) prevented the RacC-induced morphological changes but did not affect phagocytosis, suggesting that petalopodia are probably not required for RacC-induced phagocytosis. In contrast, inactivating diacylglycerol-binding motif-containing proteins by treating cells with the drug calphostin C completely inhibited phagocytosis in control and RacC WT(+) cells. These results suggest that RacC plays a role in actin cytoskeleton organization and phagocytosis in Dictyostelium.


Subject(s)
Dictyostelium/physiology , GTP Phosphohydrolases/metabolism , Androstadienes/pharmacology , Animals , Cell Membrane/physiology , Cell Membrane/ultrastructure , Dictyostelium/drug effects , Dictyostelium/ultrastructure , Enzyme Inhibitors/pharmacology , Exocytosis , GTP Phosphohydrolases/genetics , Hydrolases/metabolism , Kinetics , Lysosomes/enzymology , Microscopy, Confocal , Microscopy, Electron, Scanning , Phagocytosis , Phosphoinositide-3 Kinase Inhibitors , Pinocytosis , Wortmannin
7.
Gene ; 183(1-2): 47-51, 1996 Dec 12.
Article in English | MEDLINE | ID: mdl-8996086

ABSTRACT

We describe the cloning and characterization of a cDNA, DdApm1, encoding a putative medium chain subunit of a clathrin-associated protein (adaptor or assembly protein [AP]) complex in Dictyostelium discoideum. The DdApm1 clone is predicted to encode a polypeptide of 439 amino acids (aa) with a molecular mass of 49.9 kDa. The predicted translation product (DdApm1p) shares at least 51.7% identity and 76.3% similarity with the medium chain subunits of plasma membrane (mb)-associated clathrin AP complexes from rat and Caenorhabditis elegans. The deduced aa sequence also demonstrates significant but lesser homology to a number of medium chain subunits of Golgi-associated clathrin AP complexes. Since DdApm1p demonstrates significantly greater homology to plasma mb-associated clathrin AP complex medium chains than to their Golgi-associated counterparts, we suggest that DdApm1p may be a medium chain subunit of an AP complex involved in clathrin function at the plasma mb of D. discoideum. Southern blot analysis indicated that DdApm1 gene defines a single copy gene in the D. discoideum genome. Northern blot analysis of RNA purified at different times during growth and development demonstrated that the DdApm1 gene is expressed at relatively constant levels throughout the life cycle of the organism. DdApm1 is the first reported full-length cDNA encoding a subunit of an AP complex in D. discoideum, and thus provides the first evidence for the existence of AP complexes in this organism.


Subject(s)
Adaptor Proteins, Vesicular Transport , Carrier Proteins/genetics , Clathrin , DNA, Complementary/genetics , Dictyostelium/genetics , Protozoan Proteins , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , DNA, Protozoan/analysis , Gene Dosage , Gene Expression Regulation, Developmental , Genes, Protozoan/genetics , Molecular Sequence Data , RNA, Messenger/analysis , RNA, Protozoan/analysis , Sequence Homology, Amino Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...